Evidence map›Paper›PMID 31185663›Full record

ArticleMolecules (Basel, Switzerland)2019

A Simple HPLC Method for the Quantitative Determination of Silybin in Rat Plasma: Application to a Comparative Pharmacokinetic Study on Commercial Silymarin Products.

Eun-Sol Ha, Dong-Gyun Han, Seong-Wook Seo, Ji-Min Kim, Seon-Kwang Lee, Woo-Yong Sim, In-Soo Yoon, Min-Soo Kim

Open access · goldAbstract readComparative Study
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eun-Sol HaDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. edel@pusan.ac.kr.
Dong-Gyun HanDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. hann9607@pusan.ac.kr.
Seong-Wook SeoDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. sswook@pusan.ac.kr.
Ji-Min KimDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. jiminkim@pusan.ac.kr.
Seon-Kwang LeeDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. lsk7079@pusan.ac.kr.
Woo-Yong SimDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. popo923@pusan.ac.kr.
In-Soo YoonDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. insoo.yoon@pusan.ac.kr.ORCID 0000-0002-0997-5723
Min-Soo KimDepartment of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea. minsookim@pusan.ac.kr.
Pusan National University · KR

Funding

National Research Foundation of Korea NRF-2017R1C1B1006483, NRF-2017R1D1A3B03030252
6 · The paper itself

Abstract

Silybin (SBN) is a major active constituent of silymarin, a mixture of flavonoids found in fruits and seeds of milk thistle. The aim of this study was to describe a simple bioanalytical method for quantifying SBN in rat plasma. A simple protein deproteinization procedure with acetonitrile (ACN) was employed for plasma sample preparation. A reversed column and gradient elution of a mobile phase (mixture of phosphate buffer (pH 5.0) and ACN) were used for chromatographic separation. The selectivity, linearity (50-5000 ng/mL), precision, accuracy, recovery, matrix effect, and stability for this method were validated as per the current Food and Drug Administration (FDA) guidelines. Our method for SBN was applied to a comparative pharmacokinetic study on four different commercial silymarin products. This in vivo rat study demonstrated that product #4 significantly enhanced the relative oral bioavailability of SBN, as compared to product #1-3. Therefore, the bioanalytical method proposed herein could serve as a promising alternative for preclinical pharmacokinetic studies on silymarin products and, by extension, clinical use after partial modification and validation.

Indexed as

Administration, OralAnimalsChromatography, High Pressure LiquidMaleRats, Sprague-DawleyReference StandardsSilybinTime FactorsSilybincomparative pharmacokineticsHPLCratsilybinsilymarin product

Identifiers

PMID31185663
PMCPMC6600178
OpenAlexW2950256303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.